目的:探讨脑源性神经营养因子(BDNF)对β淀粉样蛋白(Aβ)致大鼠突触功能障碍的保护作用。方法:36只健康雄性SD大鼠随机分为对照、Aβ25-35、BDNF、不同剂量BDNF(0.02μg,0.1μg,0.5μg)+Aβ25-35等六组(n=6)。实验采用电生理学手段,利用自制的海马给药装置和刺激/记录绑定电极引导和记录大鼠在体海马CA1区场兴奋性突触后电位(fEPSPs)和高频刺激(HFS)诱导的长时程增强(LTP)。结果:①海马CA1区注射Aβ25-35(2 nmol)不影响基础性fEPSPs,但能显著抑制LTP的诱导与维持,HFS后fEPSPs平均幅度较对照组明显降低(P〈0.01);②海马CA1区注射BDNF(0.1μg)不影响基础性fEPSPs,也不影响LTP的诱导与维持,HFS后fEPSPs平均幅度与对照组相比没有明显差异(P〉0.05);③与单独给予Aβ25-35相比,不同浓度的BDNF(0.1μg,0.5μg)与Aβ25-35合用组在HFS后0 min、30 min和60 min时的fEPSPs平均幅度均明显增加(P〈0.01),并具有一定的剂量依赖性,表明BDNF预处理可有效拮抗Aβ25-35引起的LTP抑制。结论:脑内注射BDNF能够预防和拮抗由Aβ25-35引起的海马LTP损伤,提示BDNF水平的上调有助于维持正常的突触可塑性并可能改善AD患者的学习记忆功能。
Objective: To explore the effects of brain-derived neurotrophic factor(BDNF) pretreatment on β amyloid protein(Aβ)induced impairment of in vivo hippocampal long-term potentiation(LTP)in the CA1 region of rats.Methods: Thiyty-six adult male SD rats were randomly divided into six groups(n=6): control,Aβ25-35,BDNF,(0.02 μg,0.1 μg,0.5 μg) BDNF+Aβ25-35.A self-made hippocampal local drug delivery catheter and a parallel bound stimulating/recording electrode were used to deliver drugs/stimulation and record field excitatory post-synaptic potentials(fEPSPs) in the hippocampal CA1 region of rats.High-frequency stimulation(HFS) was used to induce in vivo LTP.Results: ① Aβ25-35(2 nmol) injection into CA1 region of rats did not affect the baseline fEPSPs,but inhibited the HFS-induced LTP significantly(P〈0.01).② Hippocampal CA1 injection of BDNF(0.1 μg) alone did not affect the baseline fEPSPs and HFS-induced LTP.③ Compared with Aβ25-35 alone group,the averaged amplitude of LTP in BDNF(0.1 μg and 0.5 μg) plus Aβ25-35 groups significantly increased at 0 min,30 min,and 60 min after HFS(P〈0.01),indicating that pretreatment with BDNF effectively protected against the Aβ25-35 induced depression of LTP in a dose-dependent manner.Conclusion: Intrahippocampal injection of BDNF can protect against the Aβ25-35-induced LTP impairment,suggesting that the up-regulation of BDNF in the brain could maintain the normal hippocampal synaptic plasticity and may contribute to the improvement of learning and memory in Alzheimer’s(AD) disease patients.